• Nanion Technologies: イオンチャネル研究のスマートツール

    Nanion Technologies: イオンチャネル研究のスマートツール

  • SyncroPatch 384i: HTS Automated Patch Clamp

    SyncroPatch 384i: HTS Automated Patch Clamp

  • SURFE²R 96SE: ラベルフリーのトランスポーターHTS

    SURFE²R 96SE: ラベルフリーのトランスポーターHTS

  • Dynamic Clamp: Patchliner

    Dynamic Clamp: Patchliner

  • 脂質二分子膜実験: Orbitシリーズ

    脂質二分子膜実験: Orbitシリーズ

  • CardioExcyte 96 SOL: 心筋の光ペーシング

    CardioExcyte 96 SOL: 心筋の光ペーシング

Our Product Portfolio

SyncroPatch 384

SyncroPatch 384

Patchliner

Patchliner

Port-a-Patch

Port-a-Patch

Port-a-Patch mini

Port-a-Patch mini

CardioExcyte 96

CardioExcyte 96

FLEXcyte 96

FLEXcyte 96

SURFE²R 96SE

SURFE²R 96SE

SURFE²R N1

SURFE²R N1

Orbit 16 TC

Orbit 16 TC

Orbit Mini

Orbit Mini

Vesicle Prep Pro

Vesicle Prep Pro

2018 - EAAT3 Investigated using SSM-based Electrophysiology

Icon 96SE   SURFE²R 96SE poster, Biophysics Annual Meeting 2018  logo pdf   (1.2 MB)

 Abstract:

The excitatory amino acid transporter 3 (EAAT3) is involved in the neuronal re-uptake of glutamate and plays a central role in the regulation of excitatory neurotransmission and
synaptic plasticity. EAAT3 also transports cysteine, necessary for the synthesis of glutathione and GABA. EAAT3 is expressed not only throughout the brain, but in many organs such as intestines, liver and heart. Here it seems to provide the main pathway of aspartate. Several connections of EAAT3 to severe neuronal disorders like epilepsy and schizophrenia have been described, as well as to metabolic disturbances concerning in the maintenance of aspartate and cysteine levels. This makes EAAT 3 not only an important target for functional research, but also a potential drug target.

Here we introduce a novel assay on EAAC1, a mouse homologue of EAAT3, using SSM (solid supported membrane)-based electrophysiology. SSM-based electrophysiology is a label-free electrical measuring method with very high sensitivity which enables the resolution of low turnover transport and even binding-events. Using the purified membrane of EAAC1 expressing CHO cells, we were able to determine substrate affinities and their interaction and to compare the effect of six known inhibitors directly with each other. We evaluated the assay stability and success rate. Furthermore, we were able to resolve substrate binding and to confirm the described anion conductance of the transporter.
Implementing SSM-based electrophysiology we were able to generate an efficient, robust and very flexible assay with a good throughout, which is an ideal tool for the biophysical and
pharmacological characterization of EAAC1 and even suitable for drug screening approaches.

Back

We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (tracking cookies). You can decide for yourself whether you want to allow cookies or not. Please note that if you reject them, you may not be able to use all the functionalities of the site.